EP1807208A1 - Anordnung zur integrierten und automatisierten dna- oder protein-analyse in einer einmal verwendbaren cartridge, herstellungsverfahren für eine solche cartridge und betriebsverfahren der dna- oder protein-analyse unter verwendung einer solchen cartridge - Google Patents
Anordnung zur integrierten und automatisierten dna- oder protein-analyse in einer einmal verwendbaren cartridge, herstellungsverfahren für eine solche cartridge und betriebsverfahren der dna- oder protein-analyse unter verwendung einer solchen cartridgeInfo
- Publication number
- EP1807208A1 EP1807208A1 EP05801513A EP05801513A EP1807208A1 EP 1807208 A1 EP1807208 A1 EP 1807208A1 EP 05801513 A EP05801513 A EP 05801513A EP 05801513 A EP05801513 A EP 05801513A EP 1807208 A1 EP1807208 A1 EP 1807208A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- arrangement according
- cartridge
- dna
- reagents
- pcr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502707—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the manufacture of the container or its components
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502723—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by venting arrangements
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/11—Automated chemical analysis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/2575—Volumetric liquid transfer
Definitions
- the invention relates to an arrangement for integrated and automated DNA or protein analysis in a single-use cartridge.
- Cartridge is a flat card in credit card format.
- the invention contemplates the production of such a cartridge.
- the invention also relates to an operating method for DNA or protein analysis using such a cartridge.
- a PCR polymerase chain reaction
- amplification selective DNA amplification
- the object of the invention is the realization of a low-cost, easy-to-handle, complete DNA or protein analysis process in a miniaturized cartridge.
- the following improvements compared to the laboratory method should be realized: - A complete integration of all substances (possibly except
- the cartridge used is small and inexpensive to produce.
- the invention is based, in particular, on WO 02/072262 A1 and the further prior art mentioned therein.
- an analysis device with dry-stored in fluid channels, stable at room temperature reagents is described, which are brought into solution by supplying water shortly before their intended use.
- the invention is furthermore based on the unpublished DE 10 2004 021780 A1 and the unpublished DE 10 2004 021822 A1.
- the subject of the invention is such a disposable cartridge with a system of microchannels and / or microcavities for a given process flow after sample taking, the cartridge having structures for receiving the dry reagents and these structures means for performing both the cell digestion on the one hand and the PCR on the other hand, but also the electrochemical detection are associated.
- the channels have different, problem-adapted structures. Spe ⁇ essential the digestion channel advantageously has stepped cross sections for optimum wetting of the dry reagent, while the PCR chamber and the Elisa reagent channels have potty-shaped wells.
- the inventive system of the geometric structures ren in microchannels or microcavities for receiving dry reagents to provide suitable conditions for DNA analysis of a hand and the other hand, protein analysis ⁇ .
- the following features and measures are essential:
- the changes introduced in the microchannel or the microcavity reagents are dryable substances with vernachläs ⁇ sigbarem vapor pressure.
- the substances which are stable at room temperature retain their properties for cell digestion and / or PCR and / or detection.
- mixtures may be formed with excipients thin films of the materials and the mixtures may thin Pa ⁇ refine layers be watertight covered.
- the reagents and auxiliaries are already introduced into depressions of the cartridge channels 4 as dry substances in the production of the cartridge.
- the reagents are not washed away by a so-called water flow, but are retained when the entire channel is filled. Only after filling the channel, the reagent spots dissolve via diffusion processes and there is a homogeneous reagent solution.
- the recesses are located at predefined intervals along the reagent channel.
- the distances can be equidistant or be arranged particularly advantageous in variable spacing patterns.
- the depressions can advantageously be filled with variable amounts of dry reagent. Through the combination of different dry reagent quantities and well spacing patterns, the desired concentration profiles of the final reagent solutions can be adjusted.
- the magnetic beads are dispensed as a suspension in the lysis channel. Evaporation of the solvent is observed to cause the beads to enter the
- the lysis reagents and the magnetic beads may be contained together in a single dry matrix.
- the card also contains the reagents for an ELISA assay. Two reagents are described in detail for the ELISA assay required, that the first agent Re ⁇ a label enzyme, and as the second reagent is an enzyme substrate.
- a detection module for the electrical detection of the hybridization processes is arranged in the cartridge.
- the detection module advantageously consists of an el-metal / plastic composite or a semiconductor-processed Silicon chip with precious metal electrodes.
- electrochemical, magnetic or piezoelectric measuring methods are suitable for electrical detection.
- an input port for a whole blood sample before ⁇ handen is in particular an input port for a whole blood sample before ⁇ handen.
- means are for supplying water vorhan ⁇ to, for example, inflow ports for connection to an ex ternal ⁇ water supply or an integrated water reservoir.
- dry buffer substances have a defined ionic strength after the supply of water.
- means for mixing a whole blood sample with water or a buffer solution are advantageously present.
- means for flowing through the lysis / bead / reagent coated microchannel or microcavity with blood or blood / water or blood / buffer mixtures are present.
- a magnetic field spe ⁇ for the invention in the cartridge in use essential for DNA analysis carried out PCR are still With ⁇ tel for generating for fixing the DNA / magnetic bead complex in the PCR cavity there.
- the PCR cavity must be able to be suitably closed and means for thermocyclization must be present.
- FIG. 2 shows the plan view of a cell disruption channel
- FIG. 3 shows the cross section through the cell disruption channel
- FIG. 5 FIG.
- FIG. 5 the top view of the PCR chamber in FIG. 1, FIGS. 6 and 7 the cross section through the PCR chamber according to FIG. 5,
- Figure 8 is a plan view of an ELISA reagent channel in Fi gur ⁇ 1, 9, 10 in accordance with the cross section of the ELISA Reagenzkanals
- FIG. 8 and FIGS. 11 to 23 show the plan view of the cartridge according to FIG. 1 in various process states during an automated evaluation.
- a cartridge 100 for an ELISA ( "enzyme-linked immunosorbent assay") - test with an elevation of the existing therein microchannel or Darge cavities system ⁇ is, the clarity, the associated function ⁇ designations are also referred to ,
- the cartridge 100 consists in detail of a plastic body 101 with there introduced fluidic structures, the one of
- FIGS. 2 to 10. 1 shows a sample port 102 with adjoining metering section 105, via which defined liquid samples for, in particular, nucleic acid analysis, for example for the analysis of white blood cells from whole blood, can be obtained in order to answer human-genomic questions.
- a channel region 110 for the cell disruption of the sample and furthermore, especially for a DNA analysis, a region 120 for a PCR (Polymerase Chain Reaction) for selective DNA amplification (amplification) to increase the concentration of the DNA to be detected so far that it can be detected in a third station.
- the actual PCR chamber can be closed by valves 122, 122 '. The detection of the thus prepared sample, in particular according to the ELISA method, then takes place in the region 130.
- From Figure 1 may also be water ports 103-103 '''he ⁇ clearly.
- water can be introduced into the Cartridge 100 as a transport and solvent.
- the cartridge 100 has an input port 102 for a whole blood sample.
- means for supplying water are present.
- microchannels or microcavities 101-131 are filled in the Nor mally ⁇ with dry buffer substances which ensure a de ⁇ finêt ionic strength to the water supply.
- dry buffer substances which ensure a de ⁇ finiert ionic strength to the water supply.
- For the blood analysis are means for mixing whole blood samples and water or the buffer solution and / or means for flowing through a microsphere coated with a lysis bead reagent or the microcavity with blood or with blood-water or blood-buffer mixture available.
- In the channel system are wide areas 106, 107, 108, 109 is provided as re ⁇ servoirs for receiving waste ( "waste").
- reference numerals 101 again identify the cartridge base body.
- the body includes a spe ⁇ essential for cell disruption ( "lysis") a shaped in a special way flow passage 111 with edges formed by the sides ⁇ step-shaped recesses 112 is used to receive me of dry reagents.
- the recesses 112 in this case have a plurality of steps with step heights of 10 to 500 .mu.m and ha ⁇ ben an extension of approximately 1 mm and a depth of about microns 100th
- reagents of this kind which in particular also contain magnetic beads for binding the released DNA, are distributed uniformly between the steps 112 via the flow channel 111.
- Magnetic beads have DNA- and protein-binding properties, provided that they have been pretreated accordingly. They may interfere with DNA-binding properties. optionally also be coated with antibodies.
- FIGS. 5 to 7 show the structure of a PCR chamber 120 in the cartridge main body 101 with flow channel 111.
- the valve arrangement for completing the PCR chamber in the case of appropriate use is not shown here. It is essential that in the PCR chamber 120 round cylindrical recesses 124, 124 'for receiving specific reagents 127, 127 ', which are needed in carrying out the PCR, are present. Specifically, it is shown in FIG. 7 that a dry-storable, room temperature-stable PCR reagent 127, 127 'is initially covered by a paraffin layer 128, 128'.
- FIGS. 8 to 10 show the structure and the structure of the ELISA reagent channels 131 and 131 'from FIG. 1.
- well-shaped depressions 132 to 132 6' are present which are suitable for receiving pre-dosed and pre-ported quantities Reagents for the ELISA process according to FIG. 9 are suitable.
- This is described in detail in WO 02/072262 A1, which has already been cited at the outset as state of the art, to which reference is likewise expressly made in the present context (“Incorporation by Reference").
- the circular cylindrical recesses 132-132 6 'with dry reagents 133-133 6' filled dar ⁇ provided.
- a first reagent realizes a labeling enzyme and a second reagent an enzyme substrate, as is known to be required in the hybridization of the sample optionally prepared by a PCR with specific capture probes.
- area 130 of the detection may be in a module of a precious metal / plastic composite are different sensors for Erfas ⁇ solution of biochemical reactions.
- semiconductor-processed chips ie in particular silicon-based sensors, the signals electrically detected and processed immediately.
- electrochemical, magnetic and / or piezoelectric measuring methods with related sensors are also possible.
- the cartridge 100 according to FIG. 1 is shown in plan view, with the area of the cartridge 100 active during the analysis process being marked.
- the cartridge 100 is transformed into an analyzer, which is not shown in detail in the figures and not Jacobs ⁇ tand the present patent application, is inserted.
- the enzyme-substrate solution flows via the Detektionsmo ⁇ module 130 for enzymatic-electrochemical detection of hybridization in the waste area 109 (Waste 4).
- the resulting signals can be read out electrically and processor-based evaluated according to a predetermined program.
- the cartridge described in detail with channels and cavities with reference to FIG. 1 is made of a polymer material, such as polycarbonate, for example by injection molding.
- the card base body 101 is produced with structures that are open at the top, and the reagents are spotted into the initially open channels or cavities and then dried.
- the detection module is incorporated in a suitable manner in the cartridge, insbesonde ⁇ re glued.
- the channels and the cavities are provided , for example, with an elastic film as the top cover and are therefore closed for the intended use.
- the detection chamber is first flushed with an antibody solution carrying an enzyme label (ELISA reagent 1). Then, the rinsing of the detection chamber with enzyme substrate (ELISA reagent 2). The electrochemical measurements are carried out in a manner known per se at predeterminable, different temperatures and changeable flow rates of the enzyme-substrate solution.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Clinical Laboratory Science (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004050576 | 2004-10-15 | ||
PCT/EP2005/055303 WO2006042838A1 (de) | 2004-10-15 | 2005-10-17 | Anordnung zur integrierten und automatisierten dna- oder protein-analyse in einer einmal verwendbaren cartridge, herstellungsverfahren für eine solche cartridge und betriebsverfahren der dna- oder protein-analyse unter verwendung einer solchen cartridge |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1807208A1 true EP1807208A1 (de) | 2007-07-18 |
EP1807208B1 EP1807208B1 (de) | 2013-03-20 |
Family
ID=35432485
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP05801513A Active EP1807208B1 (de) | 2004-10-15 | 2005-10-17 | Anordnung zur integrierten und automatisierten dna- oder protein-analyse in einer einmal verwendbaren cartridge, herstellungsverfahren für eine solche cartridge und betriebsverfahren der dna- oder protein-analyse unter verwendung einer solchen cartridge |
EP05803183.2A Active EP1796838B1 (de) | 2004-10-15 | 2005-10-17 | Verfahren zur durchführung einer elektrochemischen messung an einer flüssigen messprobe in einer über leitungen zugänglichen messkammer |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP05803183.2A Active EP1796838B1 (de) | 2004-10-15 | 2005-10-17 | Verfahren zur durchführung einer elektrochemischen messung an einer flüssigen messprobe in einer über leitungen zugänglichen messkammer |
Country Status (5)
Country | Link |
---|---|
US (2) | US7851227B2 (de) |
EP (2) | EP1807208B1 (de) |
JP (1) | JP4546534B2 (de) |
CN (2) | CN101039751B (de) |
WO (2) | WO2006042838A1 (de) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10816563B2 (en) | 2005-05-25 | 2020-10-27 | Boehringer Ingelheim Vetmedica Gmbh | System for operating a system for the integrated and automated analysis of DNA or protein |
PL1883474T3 (pl) * | 2005-05-25 | 2021-10-18 | Boehringer Ingelheim Vetmedica Gmbh | System do zintegrowanej i zautomatyzowanej analizy dna lub białka oraz sposób działania takiego systemu |
JP2008128907A (ja) * | 2006-11-22 | 2008-06-05 | Fujifilm Corp | マイクロ流路チップ |
WO2008137212A1 (en) * | 2007-05-02 | 2008-11-13 | Siemens Healthcare Diagnostics Inc. | Piezo dispensing of a diagnostic liquid into microfluidic devices |
CN101970111B (zh) | 2007-06-21 | 2013-09-11 | 简·探针公司 | 用于执行处理的仪器和容器 |
EP2087934A1 (de) | 2008-02-07 | 2009-08-12 | Qiagen GmbH | Verfahren und Vorrichtung zur automatisierten Prozessierung einer Probe |
US9664619B2 (en) | 2008-04-28 | 2017-05-30 | President And Fellows Of Harvard College | Microfluidic device for storage and well-defined arrangement of droplets |
US20140342381A1 (en) * | 2008-08-11 | 2014-11-20 | Banyan Biomarkers, Inc. | Devices and methods for biomarker detection process and assay of neurological condition |
US9034277B2 (en) * | 2008-10-24 | 2015-05-19 | Honeywell International Inc. | Surface preparation for a microfluidic channel |
JP5242465B2 (ja) * | 2009-03-18 | 2013-07-24 | 株式会社東芝 | 検体検出装置 |
WO2010119377A1 (en) * | 2009-04-15 | 2010-10-21 | Koninklijke Philips Electronics N.V. | A gas-free fluid chamber |
DE102009019650A1 (de) * | 2009-04-30 | 2010-11-04 | Siemens Aktiengesellschaft | Kartusche und Betriebsverfahren für Reagenzien eines Biosensorsystems |
AU2010257118B2 (en) | 2009-06-04 | 2014-08-28 | Lockheed Martin Corporation | Multiple-sample microfluidic chip for DNA analysis |
CN102803483B (zh) | 2009-06-12 | 2014-04-30 | 精密公司 | 用于微流体装置中taq 聚合酶的干燥储存的可再水合基质 |
WO2010144683A2 (en) | 2009-06-12 | 2010-12-16 | Micronics, Inc. | Compositions and methods for dehydrated storage of on-board reagents in microfluidic devices |
US8273300B2 (en) * | 2009-07-09 | 2012-09-25 | Siemens Medical Solutions Usa, Inc. | Modular system for radiosynthesis with multi-run capabilities and reduced risk of radiation exposure |
US8435454B2 (en) * | 2009-07-09 | 2013-05-07 | Siemens Medical Solutions Usa, Inc. | Modular system for radiosynthesis with multi-run capabilities and reduced risk of radiation exposure |
US20110091873A1 (en) * | 2009-10-21 | 2011-04-21 | Microfluidic Systems, Inc. | Integrated sample preparation and amplification for nucleic acid detection from biological samples |
GB201014805D0 (en) | 2010-09-07 | 2010-10-20 | Multi Sense Technologies Ltd | Microfluidics based assay device |
CA2814720C (en) | 2010-10-15 | 2016-12-13 | Lockheed Martin Corporation | Micro fluidic optic design |
US8718948B2 (en) | 2011-02-24 | 2014-05-06 | Gen-Probe Incorporated | Systems and methods for distinguishing optical signals of different modulation frequencies in an optical signal detector |
WO2013053855A1 (en) | 2011-10-11 | 2013-04-18 | Qiagen Gmbh | Sample processing method and sample processing cartridge |
JP5807542B2 (ja) | 2011-12-22 | 2015-11-10 | 株式会社島津製作所 | 対象成分を操作するためのチップデバイス及びそれを用いた方法 |
EP2795328B1 (de) | 2011-12-23 | 2019-05-01 | Abbott Point of Care Inc. | Integrierte prüfvorrichtung für optische und elektrochemische testverfahren |
EP2795339B1 (de) | 2011-12-23 | 2018-12-12 | Abbott Point of Care Inc. | Optische prüfvorrichtung mit pneumatischer probenaktivierung |
US9194859B2 (en) | 2011-12-23 | 2015-11-24 | Abbott Point Of Care Inc. | Reader devices for optical and electrochemical test devices |
JP6133063B2 (ja) | 2012-01-20 | 2017-05-24 | オーソ−クリニカル・ダイアグノスティックス・インコーポレイテッドOrtho−Clinical Diagnostics, Inc. | 角部周囲の均一な流れを有するアッセイ装置 |
US9322054B2 (en) | 2012-02-22 | 2016-04-26 | Lockheed Martin Corporation | Microfluidic cartridge |
DE102012205171B3 (de) | 2012-03-29 | 2013-09-12 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Integriertes Einweg-Chipkartuschensystem für mobile Multiparameteranalysen chemischer und/oder biologischer Substanzen |
US9213043B2 (en) | 2012-05-15 | 2015-12-15 | Wellstat Diagnostics, Llc | Clinical diagnostic system including instrument and cartridge |
US9625465B2 (en) | 2012-05-15 | 2017-04-18 | Defined Diagnostics, Llc | Clinical diagnostic systems |
US9081001B2 (en) | 2012-05-15 | 2015-07-14 | Wellstat Diagnostics, Llc | Diagnostic systems and instruments |
DE102012107651A1 (de) * | 2012-08-21 | 2014-02-27 | Astrium Gmbh | Verfahren zur Durchführung einer biochemischen Analyse, insbesondere im Weltraum |
GB201216454D0 (en) * | 2012-09-14 | 2012-10-31 | Carclo Technical Plastics Ltd | Sample metering device |
ES2704424T5 (es) * | 2013-07-05 | 2022-05-20 | Thinxxs Microtechnology Gmbh | Célula de flujo con sustancia seca integrada |
US10233491B2 (en) * | 2015-06-19 | 2019-03-19 | IntegenX, Inc. | Valved cartridge and system |
GB201611442D0 (en) | 2016-06-30 | 2016-08-17 | Lumiradx Tech Ltd | Fluid control |
ES2822089T3 (es) | 2016-10-07 | 2021-04-29 | Boehringer Ingelheim Vetmedica Gmbh | Dispositivo de análisis y método para examinar una muestra |
BR112019006655A2 (pt) | 2016-10-07 | 2019-07-02 | Boehringer Ingelheim Vetmedica Gmbh | método e sistema de análise para testagem de uma amostra |
GB201704747D0 (en) * | 2017-01-05 | 2017-05-10 | Illumina Inc | Reagent mixing system and methods |
CN109536374A (zh) * | 2018-11-27 | 2019-03-29 | 南京先进激光技术研究院 | 一种具有避免气泡产生结构的试剂反应管 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4486097A (en) * | 1981-09-09 | 1984-12-04 | E. I. Du Pont De Nemours & Company, Inc. | Flow analysis |
US4963498A (en) | 1985-08-05 | 1990-10-16 | Biotrack | Capillary flow device |
US5770029A (en) * | 1996-07-30 | 1998-06-23 | Soane Biosciences | Integrated electrophoretic microdevices |
US5482862A (en) * | 1991-04-04 | 1996-01-09 | The Dow Chemical Company | Methods for the on-line analysis of fluid streams |
JPH0777305A (ja) * | 1993-09-08 | 1995-03-20 | Tokyo Gas Co Ltd | 窒素酸化物低発生バ−ナ装置す |
EP0738395A1 (de) * | 1994-11-07 | 1996-10-23 | Laboratoires Merck-Clevenot | Automatisches gerät für immunoassay |
CA2146177C (en) * | 1995-04-03 | 2000-09-05 | Adrian P. Wade | Intelligent flow analysis network |
US6126804A (en) * | 1997-09-23 | 2000-10-03 | The Regents Of The University Of California | Integrated polymerase chain reaction/electrophoresis instrument |
JP4627395B2 (ja) * | 1999-08-11 | 2011-02-09 | 旭化成株式会社 | 分析用カートリッジ及び送液制御装置 |
EP1134294A3 (de) * | 2000-03-16 | 2004-06-30 | Kabushiki Kaisha Toshiba | Verfahren zur Synthese eines immobilisierten Nukleinsäurestranges |
DE10111457B4 (de) * | 2001-03-09 | 2006-12-14 | Siemens Ag | Diagnoseeinrichtung |
DE10111458B4 (de) * | 2001-03-09 | 2008-09-11 | Siemens Ag | Analyseeinrichtung |
DE10140565B4 (de) * | 2001-08-18 | 2006-06-29 | Roche Diagnostics Gmbh | Vorrichtung zur Gas- oder Flüssigkeitsabscheidung aus microfluidischen Durchflusssystemen |
US7258837B2 (en) * | 2001-12-05 | 2007-08-21 | University Of Washington | Microfluidic device and surface decoration process for solid phase affinity binding assays |
US7122153B2 (en) * | 2003-01-08 | 2006-10-17 | Ho Winston Z | Self-contained microfluidic biochip and apparatus |
EP1716249A2 (de) * | 2003-12-31 | 2006-11-02 | Applera Corporation, Applied Biosystems Group | Quantitative amplifikation und bestimmung geringer anzahlen von zielpolynukleotiden |
DE102004021822B3 (de) * | 2004-04-30 | 2005-11-17 | Siemens Ag | Verfahren und Anordnung zur DNA-Amplifikation mittels PCR unter Einsatz von Trockenreagenzien |
DE102004021780B4 (de) * | 2004-04-30 | 2008-10-02 | Siemens Ag | Verfahren und Anordnung zur DNA-Isolierung mit Trockenreagenzien |
DE102004050510B4 (de) * | 2004-10-15 | 2012-01-12 | Siemens Ag | Verfahren zur Ventilsteuerung bei der Thermozyklisierung einer Substanz zwecks PCR und zugehörige Anordnung |
-
2005
- 2005-10-17 US US11/665,331 patent/US7851227B2/en active Active
- 2005-10-17 WO PCT/EP2005/055303 patent/WO2006042838A1/de active Application Filing
- 2005-10-17 EP EP05801513A patent/EP1807208B1/de active Active
- 2005-10-17 EP EP05803183.2A patent/EP1796838B1/de active Active
- 2005-10-17 CN CN2005800352245A patent/CN101039751B/zh not_active Expired - Fee Related
- 2005-10-17 WO PCT/EP2005/011156 patent/WO2006042734A1/de active Application Filing
- 2005-10-17 CN CNB2005800352122A patent/CN100534619C/zh not_active Expired - Fee Related
- 2005-10-17 JP JP2007536193A patent/JP4546534B2/ja not_active Expired - Fee Related
- 2005-10-17 US US11/665,380 patent/US20090130658A1/en not_active Abandoned
Non-Patent Citations (1)
Title |
---|
See references of WO2006042838A1 * |
Also Published As
Publication number | Publication date |
---|---|
JP4546534B2 (ja) | 2010-09-15 |
CN101039751A (zh) | 2007-09-19 |
WO2006042734A1 (de) | 2006-04-27 |
CN100534619C (zh) | 2009-09-02 |
JP2008517259A (ja) | 2008-05-22 |
US7851227B2 (en) | 2010-12-14 |
CN101039750A (zh) | 2007-09-19 |
EP1796838A1 (de) | 2007-06-20 |
EP1807208B1 (de) | 2013-03-20 |
US20090130658A1 (en) | 2009-05-21 |
WO2006042838A1 (de) | 2006-04-27 |
US20090136922A1 (en) | 2009-05-28 |
CN101039751B (zh) | 2010-05-05 |
EP1796838B1 (de) | 2014-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1807208B1 (de) | Anordnung zur integrierten und automatisierten dna- oder protein-analyse in einer einmal verwendbaren cartridge, herstellungsverfahren für eine solche cartridge und betriebsverfahren der dna- oder protein-analyse unter verwendung einer solchen cartridge | |
DE102004021780B4 (de) | Verfahren und Anordnung zur DNA-Isolierung mit Trockenreagenzien | |
DE602004013339T2 (de) | Mischen in mikrofluidvorrichtungen | |
EP1846160B1 (de) | Neuartige mikrofluidische probenträger | |
DE60021077T2 (de) | Vorrichtung und verfahren zur probenabgabe | |
DE60214851T2 (de) | Mikrofluidische vorrichtung und verfahren für chemische versuche | |
EP2821138B1 (de) | Flusszelle mit integrierter Trockensubstanz | |
DE10058394C1 (de) | Verfahren für die biochemische Analytik und zugehörige Anordnung | |
EP2623200A2 (de) | Mikrostrukturierte Plattform und Verfahren zum Handhaben einer Fluessigkeit | |
EP3143119B1 (de) | Vorrichtung und verfahren zum aufbereiten einer biologischen probe und analysesystem zum analysieren einer biologischen probe | |
DE102007019695A1 (de) | Küvette für die optische Analyse kleiner Volumina | |
DE102005049976A1 (de) | Anordnung zur integrierten und automatisierten DNA- oder Protein-Analyse in einer einmal verwendbaren Cartridge, Herstellungsverfahren für eine solche Cartridge und Betriebsverfahren der DNA- oder Protein-Analyse unter Verwendung einer solchen Cartridge | |
EP3131676A1 (de) | Mikrofluidik-modul und kassette für die immunologische und molekulare diagnostik in einem analyseautomaten | |
EP2836302B1 (de) | Verfahren und vorrichtung zur gezielten prozessführung in einem mikrofluidik-prozessor mit integrierten aktiven elementen | |
EP1165227B1 (de) | Mikrosäulenreaktor | |
EP1843833B1 (de) | Verfahren und vorrichtung zur dosierung und durchmischung kleiner flüssigkeitsmengen, apparat und verwendung | |
DE102009005925B4 (de) | Vorrichtung und Verfahren zur Handhabung von Biomolekülen | |
DE10152690A1 (de) | Durchflussreaktionskammer für Sensorchips | |
WO2014060998A1 (de) | Integriertes mikrofluidisches bauteil zur anreicherung und extraktion biologischer zellbestandteile | |
WO2016062457A1 (de) | Mikrofluidisches system sowie verfahren zum analysieren einer probenlösung und verfahren zum herstellen eines mikrofluidischen systems zum analysieren einer probenlösung | |
EP1404447B1 (de) | Analysevorrichtung | |
EP1510254A2 (de) | Verfahren und Vorrichtung zur Bestimmung von Analyten in einer Flüssigkeit | |
DE102005000834B4 (de) | Verfahren und Vorrichtung zur Dosierung und Durchmischung kleiner Flüssigkeitsmengen | |
Biswas | Automatic processing of solutions for integrated microfluidic biosensing devices |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20070322 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): DE FR GB |
|
DAX | Request for extension of the european patent (deleted) | ||
RBV | Designated contracting states (corrected) |
Designated state(s): DE FR GB |
|
17Q | First examination report despatched |
Effective date: 20100128 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: SIEMENS AKTIENGESELLSCHAFT |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): DE FR GB |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 502005013572 Country of ref document: DE Effective date: 20130516 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20140102 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 502005013572 Country of ref document: DE Effective date: 20140102 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R081 Ref document number: 502005013572 Country of ref document: DE Owner name: BOEHRINGER INGELHEIM VETMEDICA GMBH, DE Free format text: FORMER OWNER: SIEMENS AKTIENGESELLSCHAFT, 80333 MUENCHEN, DE Effective date: 20130320 Ref country code: DE Ref legal event code: R081 Ref document number: 502005013572 Country of ref document: DE Owner name: BOEHRINGER INGELHEIM VETMEDICA GMBH, DE Free format text: FORMER OWNER: SIEMENS AKTIENGESELLSCHAFT, 80333 MUENCHEN, DE Effective date: 20140612 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E Free format text: REGISTERED BETWEEN 20140710 AND 20140716 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: TP Owner name: BOEHRINGER INGELHEIM VETMEDICA GMBH, DE Effective date: 20140930 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 11 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 12 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 13 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20211022 Year of fee payment: 17 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20211021 Year of fee payment: 17 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20220620 Year of fee payment: 18 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20221017 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221017 |